Zcube

Hyivy Health develops an innovative pelvic rehabilitation device aimed at addressing the needs of women who experience pelvic health complications. Recognizing that one in three women will face such challenges in their lifetime, the company provides a solution that offers quantifiable data on the pelvic floor. This device incorporates multiple biosensors and mechanical functions to deliver three distinct therapies, enabling effective treatment monitoring and personalized rehabilitation. By allowing both patients and clinicians to track progress and adapt treatment plans, Hyivy Health enhances the overall rehabilitation experience, making it more effective and comfortable.

Vilimed is a medical device development company that involves in the development of vibration tech which is a therapeutic device developed for hand tremor reduction.

Hyivy Health develops an innovative pelvic rehabilitation device aimed at addressing the needs of women who experience pelvic health complications. Recognizing that one in three women will face such challenges in their lifetime, the company provides a solution that offers quantifiable data on the pelvic floor. This device incorporates multiple biosensors and mechanical functions to deliver three distinct therapies, enabling effective treatment monitoring and personalized rehabilitation. By allowing both patients and clinicians to track progress and adapt treatment plans, Hyivy Health enhances the overall rehabilitation experience, making it more effective and comfortable.

PharmEste s.r.l., a biopharmaceutical company, engages in the discovery and development of transient receptor potential (TRP) channel therapeutics for the treatment of neuropathic pain, overactive bladder, and other TRP-mediated diseases. It develops PHE377, a TRPV1 antagonist for the treatment of neuropathic pain.

ProtAffin is a biotechnology company in Austria developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures. ProtAffin's products are first-in-class engineered versions of human proteins which bind to cell surface glycans (sugars) to affect their biological activity. Activated versions of specific cell surface glycans underlie inflammatory processes in several diseases including rheumatoid arthritis, chronic obstructive pulmonary disorder, Crohn's disease and cancer and represent a rich and relatively under-investigated class of potential drug targets for the pharmaceutical and biotechnology industries. Protaffin's approach is entirely innovative and opens up glycans as druggable targets through the use of its CellJammer® discovery platform.

ProtAffin is a biotechnology company in Austria developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures. ProtAffin's products are first-in-class engineered versions of human proteins which bind to cell surface glycans (sugars) to affect their biological activity. Activated versions of specific cell surface glycans underlie inflammatory processes in several diseases including rheumatoid arthritis, chronic obstructive pulmonary disorder, Crohn's disease and cancer and represent a rich and relatively under-investigated class of potential drug targets for the pharmaceutical and biotechnology industries. Protaffin's approach is entirely innovative and opens up glycans as druggable targets through the use of its CellJammer® discovery platform.

SuppreMol is a privately held biotechnology company that specializes in developing therapeutics for autoimmune and allergic diseases. The company is at the forefront of a novel approach aimed at treating these conditions by targeting their underlying causes rather than just alleviating symptoms. SuppreMol focuses on the development of soluble Fc-gamma receptors, which are recombinant autologous therapeutic proteins designed to exert specific immunoregulatory effects. This innovative strategy positions the company as a significant player in the field of immunotherapy, with the potential to advance treatment options for patients suffering from a range of autoimmune disorders.